14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $83.89 Tuesday, 23rd Apr 2024 AXSM stock ended at $73.08. This is 2.78% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.73% from a day low at $70.30 to a day high of $74.33.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Dec 03, 2020 $75.00 $77.85 $72.95 $77.15 425 718
Dec 02, 2020 $71.92 $74.28 $69.38 $73.96 467 550
Dec 01, 2020 $76.26 $76.49 $70.92 $71.45 673 738
Nov 30, 2020 $74.68 $74.68 $70.86 $72.49 274 309
Nov 27, 2020 $73.35 $75.33 $73.13 $75.18 127 108
Nov 25, 2020 $72.52 $73.82 $71.31 $73.42 162 271
Nov 24, 2020 $71.73 $73.17 $69.50 $72.29 249 697
Nov 23, 2020 $73.16 $73.60 $70.52 $70.92 239 813
Nov 20, 2020 $73.06 $74.43 $71.75 $72.44 247 096
Nov 19, 2020 $72.47 $73.77 $71.86 $73.27 147 205
Nov 18, 2020 $75.99 $77.48 $72.16 $72.47 245 799
Nov 17, 2020 $73.56 $75.97 $72.54 $75.92 308 562
Nov 16, 2020 $75.54 $75.90 $72.93 $74.29 246 767
Nov 13, 2020 $72.68 $75.26 $71.93 $74.18 280 425
Nov 12, 2020 $72.63 $74.00 $70.75 $72.33 243 317
Nov 11, 2020 $70.26 $73.06 $68.03 $72.82 285 241
Nov 10, 2020 $69.08 $70.96 $67.44 $70.00 389 176
Nov 09, 2020 $69.18 $73.22 $68.03 $68.82 341 335
Nov 06, 2020 $69.58 $69.89 $66.32 $67.46 357 061
Nov 05, 2020 $75.00 $75.00 $68.77 $69.51 574 382
Nov 04, 2020 $69.50 $75.32 $69.44 $74.73 346 501
Nov 03, 2020 $67.90 $69.93 $66.43 $69.44 238 959
Nov 02, 2020 $66.98 $67.88 $65.00 $66.86 292 110
Oct 30, 2020 $67.21 $68.19 $65.32 $66.31 343 928
Oct 29, 2020 $66.61 $68.58 $65.80 $68.03 236 966
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT